Chargement en cours...

5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.

Treatment of rats with reserpine in order to disrupt vesicular amine storage reduces 5-hydroxytryptamine (5-HT) levels throughout brain by 90-95%. Despite the drastic reduction in brain 5-HT content by reserpine, the 5-HT releasing drug p-chloramphetamine (PCA) produces a behavioural syndrome in res...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kuhn, D. M., Wolf, W. A., Youdim, M. B.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1985
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1987217/
https://ncbi.nlm.nih.gov/pubmed/2579697
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!